Indus Towers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 8:08 pm

Quick Insight

Indus Towers Ltd, with a share price of 343 and a market cap of 92,315 Cr., presents an intriguing investment opportunity in the telecom equipment industry. With a P/E ratio of 9.48, ROE of 32.5%, and ROCE of 29.0%, the company demonstrates solid profitability and efficient capital utilization. Operating at an OPM of 54% and boasting a Net Profit of 9,932 Cr., Indus Towers shows strong operational performance. However, with significant borrowings amounting to ₹21,156 Cr. and a CCC of 58 days, prudent financial management is crucial. The P/BV ratio of 2.71x and ICR of 12.96x indicate reasonable valuation and good debt coverage. In conclusion, while Indus Towers exhibits robust financial metrics, investors should closely monitor its leverage and working capital efficiency for sustained growth.

Competitors of Indus Towers Ltd

All Competitor Stocks of Indus Towers Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:55 pm

Below is a detailed analysis of the quarterly data for Indus Towers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 8,058.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,727.00 Cr. (Mar 2025) to 8,058.00 Cr., marking an increase of 331.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,668.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,332.00 Cr. (Mar 2025) to 3,668.00 Cr., marking an increase of 336.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 4,390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,395.00 Cr. (Mar 2025) to 4,390.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 54.00%. The value appears to be declining and may need further review. It has decreased from 57.00% (Mar 2025) to 54.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 92.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 7.00 Cr..
• For Interest, as of Jun 2025, the value is 437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 431.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1,704.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,693.00 Cr. (Mar 2025) to 1,704.00 Cr., marking an increase of 11.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 2,334.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,363.00 Cr. (Mar 2025) to 2,334.00 Cr., marking a decrease of 29.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 1,737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,779.00 Cr. (Mar 2025) to 1,737.00 Cr., marking a decrease of 42.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.44. The value appears to be declining and may need further review. It has decreased from 6.60 (Mar 2025) to 6.44, marking a decrease of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:56 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Indus Towers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2,638.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,695.00 Cr. (Mar 2024) to 2,638.00 Cr., marking a decrease of 57.00 Cr..
• For Reserves, as of Mar 2025, the value is 29,860.00 Cr.. The value appears strong and on an upward trend. It has increased from 24,344.00 Cr. (Mar 2024) to 29,860.00 Cr., marking an increase of 5,516.00 Cr..
• For Borrowings, as of Mar 2025, the value is 21,156.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20,531.00 Cr. (Mar 2024) to 21,156.00 Cr., marking an increase of 625.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 9,516.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,298.00 Cr. (Mar 2024) to 9,516.00 Cr., marking an increase of 1,218.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 63,170.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55,868.00 Cr. (Mar 2024) to 63,170.00 Cr., marking an increase of 7,302.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 44,380.00 Cr.. The value appears strong and on an upward trend. It has increased from 39,300.00 Cr. (Mar 2024) to 44,380.00 Cr., marking an increase of 5,080.00 Cr..
• For CWIP, as of Mar 2025, the value is 567.00 Cr.. The value appears strong and on an upward trend. It has increased from 422.00 Cr. (Mar 2024) to 567.00 Cr., marking an increase of 145.00 Cr..
• For Investments, as of Mar 2025, the value is 1,486.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 1,486.00 Cr., marking an increase of 1,483.00 Cr..
• For Other Assets, as of Mar 2025, the value is 16,737.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,143.00 Cr. (Mar 2024) to 16,737.00 Cr., marking an increase of 594.00 Cr..
• For Total Assets, as of Mar 2025, the value is 63,170.00 Cr.. The value appears strong and on an upward trend. It has increased from 55,868.00 Cr. (Mar 2024) to 63,170.00 Cr., marking an increase of 7,302.00 Cr..

Notably, the Reserves (29,860.00 Cr.) exceed the Borrowings (21,156.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Indus Towers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 37.31. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.31, marking an increase of 14.91.
• For Diluted EPS (Rs.), as of Mar 25, the value is 37.31. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.31, marking an increase of 14.91.
• For Cash EPS (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has increased from 44.88 (Mar 24) to 61.91, marking an increase of 17.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.19. It has increased from 100.33 (Mar 24) to 123.19, marking an increase of 22.86.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.19. It has increased from 100.33 (Mar 24) to 123.19, marking an increase of 22.86.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 114.18. It has increased from 106.13 (Mar 24) to 114.18, marking an increase of 8.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 80.32. This value is within the healthy range. It has increased from 55.35 (Mar 24) to 80.32, marking an increase of 24.97.
• For PBIT / Share (Rs.), as of Mar 25, the value is 56.06. This value is within the healthy range. It has increased from 32.87 (Mar 24) to 56.06, marking an increase of 23.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 49.86. This value is within the healthy range. It has increased from 30.14 (Mar 24) to 49.86, marking an increase of 19.72.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 37.65. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.65, marking an increase of 15.25.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 37.65. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.65, marking an increase of 15.25.
• For PBDIT Margin (%), as of Mar 25, the value is 70.34. This value is within the healthy range. It has increased from 52.15 (Mar 24) to 70.34, marking an increase of 18.19.
• For PBIT Margin (%), as of Mar 25, the value is 49.09. This value exceeds the healthy maximum of 20. It has increased from 30.97 (Mar 24) to 49.09, marking an increase of 18.12.
• For PBT Margin (%), as of Mar 25, the value is 43.66. This value is within the healthy range. It has increased from 28.39 (Mar 24) to 43.66, marking an increase of 15.27.
• For Net Profit Margin (%), as of Mar 25, the value is 32.97. This value exceeds the healthy maximum of 10. It has increased from 21.10 (Mar 24) to 32.97, marking an increase of 11.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 32.97. This value exceeds the healthy maximum of 20. It has increased from 21.10 (Mar 24) to 32.97, marking an increase of 11.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 22.32 (Mar 24) to 30.56, marking an increase of 8.24.
• For Return on Capital Employeed (%), as of Mar 25, the value is 27.70. This value is within the healthy range. It has increased from 19.37 (Mar 24) to 27.70, marking an increase of 8.33.
• For Return On Assets (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has increased from 10.80 (Mar 24) to 15.72, marking an increase of 4.92.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.06, marking a decrease of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 0.55 (Mar 24) to 0.50, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.32, marking an increase of 0.29.
• For Quick Ratio (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.32, marking an increase of 0.29.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 12.96. This value is within the healthy range. It has decreased from 20.29 (Mar 24) to 12.96, marking a decrease of 7.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has decreased from 9.21 (Mar 24) to 7.08, marking a decrease of 2.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 88,545.22. It has increased from 82,710.71 (Mar 24) to 88,545.22, marking an increase of 5,834.51.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has increased from 2.89 (Mar 24) to 2.94, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 5. It has decreased from 5.54 (Mar 24) to 4.18, marking a decrease of 1.36.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.74 (Mar 24) to 2.93, marking an increase of 0.19.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has decreased from 2.90 (Mar 24) to 2.71, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.74 (Mar 24) to 2.93, marking an increase of 0.19.
• For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.11, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness